27 results
S-4/A
ELVN
Enliven Therapeutics Inc
19 Dec 22
Registration of securities issued in business combination transactions (amended)
9:01am
authorities;
recall of the product;
restrictions on the marketing of the product or the manufacturing process for any component thereof;
requirement … or supplements to approved applications that Imara submits;
recall of products;
fines, restitution or disgorgement of profits or revenues;
suspension of any
S-4
rmukgia9klmpq5gwlrxb
10 Nov 22
Registration of securities issued in business combination transactions
4:23pm
425
7j4r hz89akiee
13 Oct 22
Business combination disclosure
4:50pm
8-K
EX-2.1
13qjc1x6l7easm
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
10-K
j5x1wabjf6 b8so4d
5 Mar 21
Annual report
7:26am
10-Q
n6nb7x5
7 May 20
Quarterly report
8:12am
424B4
merkppfizpgad34ep12
12 Mar 20
Prospectus supplement with pricing info
4:03pm